Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment.

Scientific Reports
Heng Sheng SowJ Sjef Verbeek

Abstract

The use of Trastuzumab (Herceptin), a monoclonal antibody (mAb) targeting HER2/neu, results in an increased median survival in Her2+ breast cancer patients. The tumour mutational burden and the presence of tumour infiltrating lymphocytes (TILs) clearly correlate with response to trastuzumab. Here, we investigated if the immunogenicity of the transplantable rat-neu+ tumour cell line (TUBO) derived from a BALB/c-NeuT primary tumour is associated with the response to anti-neu mAb therapy. We compared the TUBO tumour outgrowth and tumour infiltrating T cells in isogenic (BALB/c-NeuT) and non-isogenic (WT BALB/c) recipient mice. Furthermore, therapeutic efficacy of anti-neu mAb and the contribution of T cells were examined in both mouse strains. The outgrowth of untreated tumours was significantly better in BALB/c-NeuT than WT BALB/c mice. Moreover, tumour infiltrating T cells were more abundantly present in WT BALB/c than BALB/c-NeuT mice, showing that the TUBO tumour was more immunogenic in WT BALB/c mice. In TUBO tumour bearing WT BALB/c mice, anti-neu mAb therapy resulted in an increase of tumour infiltrating T cells and long-term survival. When T cells were depleted, this strong anti-tumour effect was reduced to an outgrowth de...Continue Reading

References

Sep 24, 1999·Experimental and Molecular Pathology·H ZhangR Murali
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Oct 25, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S RoveroG Forni
Mar 16, 2001·Breast Cancer Research : BCR·L Hennighausen
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José BaselgaParviz Ghahramani
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Simona RollaFrancesco Ria
Nov 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laurent ArnouldBruno P Coudert
Mar 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonino MusolinoAndrea Ardizzoni
Oct 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·John StaggMark J Smyth
Apr 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitch DowsettBrian Leyland-Jones
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezRobert B Jenkins
Apr 12, 2011·The Journal of Pathology·Metamia CiampricottiKarin E de Visser
Apr 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·John StaggMark J Smyth
Feb 1, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric D MortensonYang-Xin Fu
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Feb 6, 2014·Laboratory Animals·UNKNOWN FELASA working group on revision of guidelines for health monitoring of rodents and rabbitsM Raspa
May 8, 2015·Nature Medicine·Stephen E GouldFrederic J de Sauvage
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·David G McFaddenHarold Varmus
Dec 8, 2016·Cancer Immunology Research·Suzanne I S MoselyRobert W Wilkinson
Sep 1, 2017·Cancer Research·Martin TurcotteJohn Stagg
Dec 1, 2017·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hiroaki InoueFutoshi Akiyama
Aug 23, 2018·NPJ Breast Cancer·Esther HolgadoJavier Cortes
Nov 2, 2018·Molecular Cancer Therapeutics·Hreinn BenonissonThorbald van Hall

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
PCR
flow cytometry

Software Mentioned

FacsDIVA
FlowJo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.